Home › Companies › AGILON HEALTH INC. › 2023-2024
Compiled from SEC Form N-PX filings and AGILON HEALTH INC.’s Form 8-K, filed June 3, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of May 29, 2024: 5 items on AGILON HEALTH INC.’s Form 8-K, filed June 3, 2024: 3 elected · 2 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore AGILON HEALTH INC. in the interactive database Compare manager voting policies
These tallies are AGILON HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Ravi Sachdev | 359,574,466 | 25,246,100 | 106,890 | -- | 7,698,907 | 93% | Elected | — |
| Elect Director: Steven J. Sell | 362,777,063 | 22,042,462 | 107,931 | -- | 7,698,907 | 94% | Elected | — |
| Elect Director: William Wulf, M.D. | 359,928,894 | 24,926,633 | 71,929 | -- | 7,698,907 | 94% | Elected | — |
| 2. Ratification of Independent Registered Public Accounting Firm | 391,453,808 | 1,087,702 | 84,853 | -- | -- | 99.7% | Approved | — |
| 3. Non-Binding Vote on Executive Compensation | 318,678,236 | 66,152,444 | 96,776 | -- | 7,698,907 | 83% | Approved | — |
Source: AGILON HEALTH INC., Form 8-K, filed with the SEC on June 3, 2024 — read the filing on EDGAR.
Each item below shows how the 189 asset managers that disclosed a AGILON HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Ravi Sachdev
AGILON HEALTH INC.’s own tally for this item (“Elect Director: Ravi Sachdev”): 359,574,466 for, 25,246,100 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following three individuals were elected to the Company's Board of Directors to serve as Class III directors until the Company's 2027 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 203,220,010 for, 3,156,774 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 63,385,837 | 0 | 0 | 0 | For |
| Capital Group | 46,216,042 | 0 | 0 | 0 | For |
| Fidelity | 40,874,878 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,711,855 | 4,493 | 0 | 0 | For |
| NEW ECONOMY FUND | 9,195,960 | 0 | 0 | 0 | For |
| Hartford | 6,920,929 | 0 | 0 | 0 | For |
| Brighthouse | 3,178,179 | 4,581 | 0 | 0 | For |
| AMCAP FUND | 2,895,418 | 0 | 0 | 0 | For |
| BlackRock | 2,585,642 | 0 | 0 | 0 | For |
| Charles Schwab | 2,104,350 | 0 | 0 | 0 | For |
| Transamerica | 1,587,889 | 0 | 0 | 0 | For |
| DWS | 0 | 1,016,618 | 0 | 0 | Against |
| T. Rowe Price | 952,099 | 0 | 0 | 0 | For |
| Northwestern Mutual | 840,453 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 0 | 815,161 | 0 | 0 | Against |
| Equitable | 649,597 | 70,523 | 0 | 0 | Mixed |
| Principal | 0 | 317,160 | 0 | 0 | Against |
| John Hancock | 226,626 | 7,015 | 0 | 0 | For |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 191,122 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 175,435 | 0 | 0 | Against |
| AGF Investments Trust | 0 | 165,508 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 149,243 | 0 | 0 | 0 | For |
| Calvert | 0 | 144,974 | 0 | 0 | Against |
| Guardian Variable Products Trust | 129,607 | 0 | 0 | 0 | For |
| TIAA | 0 | 125,247 | 0 | 0 | Against |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Steven J. Sell
AGILON HEALTH INC.’s own tally for this item (“Elect Director: Steven J. Sell”): 362,777,063 for, 22,042,462 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following three individuals were elected to the Company's Board of Directors to serve as Class III directors until the Company's 2027 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 203,584,811 for, 2,791,973 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 63,385,837 | 0 | 0 | 0 | For |
| Capital Group | 46,216,042 | 0 | 0 | 0 | For |
| Fidelity | 40,874,878 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,711,855 | 4,493 | 0 | 0 | For |
| NEW ECONOMY FUND | 9,195,960 | 0 | 0 | 0 | For |
| Hartford | 6,920,929 | 0 | 0 | 0 | For |
| Brighthouse | 3,178,179 | 4,581 | 0 | 0 | For |
| AMCAP FUND | 2,895,418 | 0 | 0 | 0 | For |
| BlackRock | 2,585,642 | 0 | 0 | 0 | For |
| Charles Schwab | 2,104,350 | 0 | 0 | 0 | For |
| Transamerica | 1,587,889 | 0 | 0 | 0 | For |
| DWS | 0 | 1,016,618 | 0 | 0 | Against |
| T. Rowe Price | 952,099 | 0 | 0 | 0 | For |
| Northwestern Mutual | 840,453 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 0 | 815,161 | 0 | 0 | Against |
| Equitable | 720,120 | 0 | 0 | 0 | For |
| Principal | 0 | 317,160 | 0 | 0 | Against |
| John Hancock | 226,626 | 7,015 | 0 | 0 | For |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 191,122 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 175,435 | 0 | 0 | Against |
| AGF Investments Trust | 0 | 165,508 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 149,243 | 0 | 0 | 0 | For |
| Calvert | 0 | 144,974 | 0 | 0 | Against |
| Guardian Variable Products Trust | 129,607 | 0 | 0 | 0 | For |
| TIAA | 125,247 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: William Wulf, M.D.
AGILON HEALTH INC.’s own tally for this item (“Elect Director: William Wulf, M.D.”): 359,928,894 for, 24,926,633 against, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following three individuals were elected to the Company's Board of Directors to serve as Class III directors until the Company's 2027 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 203,337,806 for, 3,038,978 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 63,385,837 | 0 | 0 | 0 | For |
| Capital Group | 46,216,042 | 0 | 0 | 0 | For |
| Fidelity | 40,874,878 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,711,855 | 4,493 | 0 | 0 | For |
| NEW ECONOMY FUND | 9,195,960 | 0 | 0 | 0 | For |
| Hartford | 6,920,929 | 0 | 0 | 0 | For |
| Brighthouse | 3,178,179 | 4,581 | 0 | 0 | For |
| AMCAP FUND | 2,895,418 | 0 | 0 | 0 | For |
| BlackRock | 2,585,642 | 0 | 0 | 0 | For |
| Charles Schwab | 2,104,350 | 0 | 0 | 0 | For |
| Transamerica | 1,587,889 | 0 | 0 | 0 | For |
| DWS | 0 | 1,016,618 | 0 | 0 | Against |
| T. Rowe Price | 952,099 | 0 | 0 | 0 | For |
| Northwestern Mutual | 840,453 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 0 | 815,161 | 0 | 0 | Against |
| Equitable | 649,597 | 70,523 | 0 | 0 | Mixed |
| Principal | 0 | 317,160 | 0 | 0 | Against |
| John Hancock | 226,626 | 7,015 | 0 | 0 | For |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 191,122 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 175,435 | 0 | 0 | Against |
| AGF Investments Trust | 0 | 165,508 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 149,243 | 0 | 0 | 0 | For |
| Calvert | 0 | 144,974 | 0 | 0 | Against |
| Guardian Variable Products Trust | 129,607 | 0 | 0 | 0 | For |
| TIAA | 0 | 125,247 | 0 | 0 | Against |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Combines 9 wordings of this item as funds reported it.
83% Approved · of votes cast
Description as filed by funds: To approve, by advisory vote, the compensation paid to the Company's named executive officers.
AGILON HEALTH INC.’s own tally for this item (“3. Non-Binding Vote on Executive Compensation”): 318,678,236 for, 66,152,444 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 - Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers.”
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 63,385,837 | 0 | 0 | 0 | For |
| Capital Group | 0 | 46,216,042 | 0 | 0 | Against |
| Fidelity | 40,874,878 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,716,348 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 0 | 9,195,960 | 0 | 0 | Against |
| Hartford | 6,920,929 | 0 | 0 | 0 | For |
| Brighthouse | 3,182,760 | 0 | 0 | 0 | For |
| AMCAP FUND | 0 | 2,895,418 | 0 | 0 | Against |
| BlackRock | 2,585,642 | 0 | 0 | 0 | For |
| Charles Schwab | 2,104,350 | 0 | 0 | 0 | For |
| Transamerica | 1,587,889 | 0 | 0 | 0 | For |
| DWS | 1,016,618 | 0 | 0 | 0 | For |
| T. Rowe Price | 952,099 | 0 | 0 | 0 | For |
| Northwestern Mutual | 840,453 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 815,161 | 0 | 0 | 0 | For |
| Equitable | 720,120 | 0 | 0 | 0 | For |
| Principal | 317,160 | 0 | 0 | 0 | For |
| John Hancock | 233,641 | 0 | 0 | 0 | For |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 191,122 | 0 | 0 | 0 | For |
| Goldman Sachs | 175,435 | 0 | 0 | 0 | For |
| AGF Investments Trust | 165,508 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 149,243 | 0 | 0 | 0 | For |
| Calvert | 144,974 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 129,607 | 0 | 0 | 0 | For |
| TIAA | 125,247 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 148,062,293 for, 58,314,437 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 100,000,000 | 0 | 0 | 0 | For |
| Capital Group | 1,068 | 62,616,801 | 0 | 0 | Against |
| Wellington | 52,076,558 | 0 | 0 | 0 | For |
| Morgan Stanley | 46,716,269 | 0 | 0 | 0 | For |
| Fidelity | 40,167,015 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 7,347,792 | 0 | 0 | 0 | For |
| BlackRock | 5,309,017 | 0 | 0 | 0 | For |
| State Street | 2,792,237 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,746,952 | 0 | 0 | 0 | For |
| Bridgewater | 2,642,690 | 0 | 0 | 0 | For |
| Charles Schwab | 2,231,465 | 0 | 0 | 0 | For |
| BROWN ADVISORY INC | 2,050,170 | 0 | 0 | 0 | For |
| Daventry Group, LP | 1,750,249 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,619,924 | 0 | 0 | 0 | For |
| Northern Trust | 1,012,181 | 0 | 0 | 0 | For |
| Durable Capital Partners LP | 976,133 | 0 | 0 | 0 | For |
| Man Group plc | 750,220 | 0 | 0 | 0 | For |
| Amundi | 0 | 737,772 | 0 | 0 | Against |
| Capital Research Global Investors | 0 | 697,459 | 0 | 0 | Against |
| Sessa Capital IM, L.P. | 599,875 | 0 | 0 | 0 | For |
| Vanguard | 443,144 | 0 | 0 | 0 | For |
| Goldman Sachs | 431,209 | 0 | 0 | 0 | For |
| UBS | 0 | 370,362 | 0 | 0 | Against |
| Two Sigma | 326,047 | 0 | 0 | 0 | For |
| AGF MANAGEMENT LTD | 267,680 | 0 | 0 | 0 | For |
Institutional-manager reports, all 149 managers: 275,818,784 for, 64,810,272 against, 56,342 abstained. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.
AGILON HEALTH INC.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 391,453,808 for, 1,087,702 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 206,376,784 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 63,385,837 | 0 | 0 | 0 | For |
| Capital Group | 46,216,042 | 0 | 0 | 0 | For |
| Fidelity | 40,874,878 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,716,348 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 9,195,960 | 0 | 0 | 0 | For |
| Hartford | 6,920,929 | 0 | 0 | 0 | For |
| Brighthouse | 3,182,760 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,895,418 | 0 | 0 | 0 | For |
| BlackRock | 2,585,642 | 0 | 0 | 0 | For |
| Charles Schwab | 2,104,350 | 0 | 0 | 0 | For |
| Transamerica | 1,587,889 | 0 | 0 | 0 | For |
| DWS | 1,016,618 | 0 | 0 | 0 | For |
| T. Rowe Price | 952,099 | 0 | 0 | 0 | For |
| Northwestern Mutual | 840,453 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 815,161 | 0 | 0 | 0 | For |
| Equitable | 720,120 | 0 | 0 | 0 | For |
| Principal | 317,160 | 0 | 0 | 0 | For |
| John Hancock | 233,641 | 0 | 0 | 0 | For |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 191,122 | 0 | 0 | 0 | For |
| Goldman Sachs | 175,435 | 0 | 0 | 0 | For |
| AGF Investments Trust | 165,508 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 149,243 | 0 | 0 | 0 | For |
| Calvert | 144,974 | 0 | 0 | 0 | For |
| Guardian Variable Products Trust | 129,607 | 0 | 0 | 0 | For |
| TIAA | 125,247 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 410,843,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 15.43% |
| 2 | Capital Group | 11.25% |
| 3 | Fidelity | 9.95% |
| 4 | Morgan Stanley | 5.04% |
| 5 | NEW ECONOMY FUND | 2.24% |
| 6 | Hartford | 1.68% |
| 7 | Brighthouse | 0.77% |
| 8 | AMCAP FUND | 0.70% |
| 9 | BlackRock | 0.63% |
| 10 | Charles Schwab | 0.51% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Clayton, Dubilier & Rice, LLC | 24.34% |
| 2 | Capital Group | 15.24% |
| 3 | Wellington | 12.68% |
| 4 | Morgan Stanley | 11.37% |
| 5 | Fidelity | 9.78% |
| 6 | Rock Springs Capital Management LP | 1.79% |
| 7 | BlackRock | 1.29% |
| 8 | State Street | 0.68% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 0.67% |
| 10 | Bridgewater | 0.64% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| CD&R Vector Holdings, L.P. | 24.34% | DEF14A |
| FMR LLC | 14.79% | DEF14A |
| Wellington Management | 13.83% | 13F |
| Capital World Investors | 13.44% | DEF14A |
| Morgan Stanley | 10.66% | DEF14A |
| Vanguard Group | 5.91% | 13F |
| BlackRock | 5.89% | 13F |
| FMR (Fidelity) | 3.81% | 13F |
| Goldman Sachs | 1.65% | 13F |
| State Street | 1.26% | 13F |
Percentages above are of 410,843,000 shares outstanding, as reported by AGILON HEALTH INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AGILON HEALTH INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At AGILON HEALTH INC.'s shareholder meeting held May 29, 2024, in the 2023-2024 proxy season, 189 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,468 separate fund positions. On the most widely held item on that ballot — To approve, by advisory vote, the compensation paid to the Company's named executive officers. — AGILON HEALTH INC.'s filing reports the proposal as approved, with 83% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AGILON HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2024.
AGILON HEALTH INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.